EX-10.7 13 d393013dex107.htm EX-10.7 Execution Version PATENT ASSIGNMENT between CARDIFF PROTIDES LIMITED and NUCANA BIOMED LIMITED Dated: 15th March 2012 Ref: [***]Patent Assignment • May 5th, 2020 • Cardiff
Portions of this Exhibit, indicated by the mark “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 406 of the Securities Act of 1933, as amended.
PATENT ASSIGNMENT between CARDIFF PROTIDES LIMITED and NUCANA BIOMED LIMITED Dated: 15th March 2012 Ref: [***] Portions of this Exhibit, indicated by the mark “[***],” were omitted and have been filed separately with the Securities and Exchange...Patent Assignment • September 1st, 2017 • NuCana PLC • Pharmaceutical preparations • Cardiff
Pursuant to the Assignment, Licence and Collaboration Agreement (as defined below), the Assignor has agreed to assign to the Assignee, and the Assignee is willing to accept the assignment of the Assignor’s entire right, title and interest in and to the Patents (as defined below) on the terms and conditions set out in this Assignment.
PATENT ASSIGNMENT between CARDIFF PROTIDES LIMITED and NUCANA BIOMED LIMITED Dated: 15th March 2012 Ref: [***] Portions of this Exhibit, indicated by the mark “[***],” were omitted and have been filed separately with the Securities and Exchange...Patent Assignment • August 4th, 2017 • NuCana BioMed LTD • Pharmaceutical preparations • Cardiff
Pursuant to the Assignment, Licence and Collaboration Agreement (as defined below), the Assignor has agreed to assign to the Assignee, and the Assignee is willing to accept the assignment of the Assignor’s entire right, title and interest in and to the Patents (as defined below) on the terms and conditions set out in this Assignment.